PDUFA REAUTHORIZATION LINKED TO FDA MANAGEMENT CHANGES BY REP. BARTON; USER FEE BILL HINGES ON APPROPRIATIONS PROCESS, SAYS HEALTH SUBCMTE. CHAIRMAN BILIRAKIS
Executive Summary
House Commerce/Oversight Subcommittee Chairman Barton (R-Tex.) is continuing to push for management changes at FDA as a higher priority than user fee reauthorization.
You may also be interested in...
Rep. Tauzin Ready To Negotiate With PhRMA After Resigning Committee Chair
Rep. Billy Tauzin's resignation from the chairmanship of the Energy & Commerce Committee paves the way for negotiations to begin in earnest for him to take over as president of the Pharmaceutical Research & Manufacturers of America
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011